AR030030A1 - Imidazo-5-il-aminas biciclicas, medicamentos que las contienen, su uso para la preparacion de medicamentos y procedimiento para su preparacion - Google Patents
Imidazo-5-il-aminas biciclicas, medicamentos que las contienen, su uso para la preparacion de medicamentos y procedimiento para su preparacionInfo
- Publication number
- AR030030A1 AR030030A1 ARP000105252A ARP000105252A AR030030A1 AR 030030 A1 AR030030 A1 AR 030030A1 AR P000105252 A ARP000105252 A AR P000105252A AR P000105252 A ARP000105252 A AR P000105252A AR 030030 A1 AR030030 A1 AR 030030A1
- Authority
- AR
- Argentina
- Prior art keywords
- unbranched
- alkyl
- optionally substituted
- branched
- phenyl
- Prior art date
Links
- 239000003814 drug Substances 0.000 title 2
- 150000001412 amines Chemical class 0.000 title 1
- 238000000034 method Methods 0.000 title 1
- 125000004435 hydrogen atom Chemical group [H]* 0.000 abstract 12
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 abstract 12
- 125000004209 (C1-C8) alkyl group Chemical group 0.000 abstract 11
- 229910052739 hydrogen Inorganic materials 0.000 abstract 11
- 239000001257 hydrogen Substances 0.000 abstract 11
- 125000006552 (C3-C8) cycloalkyl group Chemical group 0.000 abstract 2
- 125000006564 (C4-C8) cycloalkyl group Chemical group 0.000 abstract 2
- FCEHBMOGCRZNNI-UHFFFAOYSA-N 1-benzothiophene Chemical compound C1=CC=C2SC=CC2=C1 FCEHBMOGCRZNNI-UHFFFAOYSA-N 0.000 abstract 2
- 125000001637 1-naphthyl group Chemical group [H]C1=C([H])C([H])=C2C(*)=C([H])C([H])=C([H])C2=C1[H] 0.000 abstract 2
- 125000001622 2-naphthyl group Chemical group [H]C1=C([H])C([H])=C2C([H])=C(*)C([H])=C([H])C2=C1[H] 0.000 abstract 2
- 125000004105 2-pyridyl group Chemical group N1=C([*])C([H])=C([H])C([H])=C1[H] 0.000 abstract 2
- 125000003349 3-pyridyl group Chemical group N1=C([H])C([*])=C([H])C([H])=C1[H] 0.000 abstract 2
- 125000000339 4-pyridyl group Chemical group N1=C([H])C([H])=C([*])C([H])=C1[H] 0.000 abstract 2
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 abstract 2
- SMWDFEZZVXVKRB-UHFFFAOYSA-N Quinoline Chemical compound N1=CC=CC2=CC=CC=C21 SMWDFEZZVXVKRB-UHFFFAOYSA-N 0.000 abstract 2
- MWPLVEDNUUSJAV-UHFFFAOYSA-N anthracene Chemical compound C1=CC=CC2=CC3=CC=CC=C3C=C21 MWPLVEDNUUSJAV-UHFFFAOYSA-N 0.000 abstract 2
- 229910052799 carbon Inorganic materials 0.000 abstract 2
- YNPNZTXNASCQKK-UHFFFAOYSA-N phenanthrene Chemical compound C1=CC=C2C3=CC=CC=C3C=CC2=C1 YNPNZTXNASCQKK-UHFFFAOYSA-N 0.000 abstract 2
- 125000004178 (C1-C4) alkyl group Chemical group 0.000 abstract 1
- -1 1,1,3,3-tetramethylbutyl Chemical group 0.000 abstract 1
- KAESVJOAVNADME-UHFFFAOYSA-N 1H-pyrrole Natural products C=1C=CNC=1 KAESVJOAVNADME-UHFFFAOYSA-N 0.000 abstract 1
- WKBOTKDWSSQWDR-UHFFFAOYSA-N Bromine atom Chemical compound [Br] WKBOTKDWSSQWDR-UHFFFAOYSA-N 0.000 abstract 1
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 abstract 1
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 abstract 1
- YTPLMLYBLZKORZ-UHFFFAOYSA-N Divinylene sulfide Natural products C=1C=CSC=1 YTPLMLYBLZKORZ-UHFFFAOYSA-N 0.000 abstract 1
- PXGOKWXKJXAPGV-UHFFFAOYSA-N Fluorine Chemical compound FF PXGOKWXKJXAPGV-UHFFFAOYSA-N 0.000 abstract 1
- 241000347391 Umbrina cirrosa Species 0.000 abstract 1
- CIUQDSCDWFSTQR-UHFFFAOYSA-N [C]1=CC=CC=C1 Chemical class [C]1=CC=CC=C1 CIUQDSCDWFSTQR-UHFFFAOYSA-N 0.000 abstract 1
- 125000005073 adamantyl group Chemical group C12(CC3CC(CC(C1)C3)C2)* 0.000 abstract 1
- 125000004429 atom Chemical group 0.000 abstract 1
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 abstract 1
- 125000002619 bicyclic group Chemical group 0.000 abstract 1
- GDTBXPJZTBHREO-UHFFFAOYSA-N bromine Substances BrBr GDTBXPJZTBHREO-UHFFFAOYSA-N 0.000 abstract 1
- 229910052794 bromium Inorganic materials 0.000 abstract 1
- 125000004432 carbon atom Chemical group C* 0.000 abstract 1
- 229910052801 chlorine Inorganic materials 0.000 abstract 1
- 239000000460 chlorine Substances 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- CCGKOQOJPYTBIH-UHFFFAOYSA-N ethenone Chemical compound C=C=O CCGKOQOJPYTBIH-UHFFFAOYSA-N 0.000 abstract 1
- 125000003983 fluorenyl group Chemical group C1(=CC=CC=2C3=CC=CC=C3CC12)* 0.000 abstract 1
- 229910052731 fluorine Inorganic materials 0.000 abstract 1
- 239000011737 fluorine Substances 0.000 abstract 1
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 abstract 1
- 150000003233 pyrroles Chemical class 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 125000001424 substituent group Chemical group 0.000 abstract 1
- 125000000335 thiazolyl group Chemical group 0.000 abstract 1
- 229930192474 thiophene Natural products 0.000 abstract 1
- 150000003577 thiophenes Chemical class 0.000 abstract 1
- 125000002023 trifluoromethyl group Chemical group FC(F)(F)* 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
- C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
- C07D513/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/6561—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing systems of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring or ring system, with or without other non-condensed hetero rings
-
- C—CHEMISTRY; METALLURGY
- C40—COMBINATORIAL TECHNOLOGY
- C40B—COMBINATORIAL CHEMISTRY; LIBRARIES, e.g. CHEMICAL LIBRARIES
- C40B40/00—Libraries per se, e.g. arrays, mixtures
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Medicinal Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Rheumatology (AREA)
- Pain & Pain Management (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Abstract
Nuevas imidazo-5-il-aminas bicíclicas de la formula general (1) en la cual R1 representa C(CH3)3, (CH2)6CH, fenilo eventualmente sustituido, C4-8-cicloalquilo, CH2CH2R (R = 4-MORFOLINO), 1,1,3,3- tetrametilbutilo o CH2Ra, en que Ra representa hidrogeno, C1-8-alquilo (ramificado o no ramificado), fenilo eventualmente sustituido, CO(OR') (R' = C1-8-alquilo (ramificado o no ramificado)), PO(OR'')2 (R'' = C1-4-alquilo (ramificado o no ramificado ) o Si (RxRyRz) (en donde Rx, Ry y Rz independientemente entre sí representan C1-8-alquilo (ramificado o no ramificado) , C4-8-cicloalquilo o fenilo ), R2 representa hidrogeno, CORb, en que Rb representa hidrogeno, C1-8-alquilo (ramificado o no ramificado) C3-8-cicloalquilo, CH2CH2CO (OR') (R' = C1-8-alquilo (ramificado o no ramificado), adamantilo, fenilo eventualmente sustituido 1-naftilo, eventualmente sustituido, 2-naftilo, 2-piridilo, 3-piridilo, 4-piridilo, tiazolilo o furoilo, CH2Rc, en donde Rc representa hidrogeno, C1-8-alquilo (ramificado o no ramificado) o fenilo eventualmente sustituido, CH2CH2Rd, en que Rd representa fenilo eventualmente sustituido o CONHRe, en donde Re representa fenilo, R3 representa C1-8-alquilo (ramificado o no ramificado), C3-8-cicloalquilo, fenilo eventualmente sustituido, 1-naftilo eventualmente sustituido, 2-naftilo, quinolina, antraceno, fenantreno, benzotiofeno, benzofurfurilo, pirrol eventualmente sustituido, 2-piridilo, 3-piridilo, 4-piridilo, furfurilo eventualmente sustituido o tiofeno eventualmente sustituido, X representa CR5, N o S e Y para el caso que X sea igual a S representa CR6 o N; y en todos los demás casos Y representa N, y en donde la línea de trazos en el elemento estructural, (formula 2) significa que en los casos en que X representa S, Y está ligado a través de una doble ligadura con el átomo de carbono al que está ligado R4 y en todos los demás casos uno de los grupos X está ligado a través de una doble ligadura con el átomo de carbono que lleva el sustituyente R4 y el otro tiene un átomo de hidrogeno adicional, R4, R5 y R6 representan independientemente entre sí hidrogeno, C1-8-alquilo (ramificado o no ramificado), fluor, cloro, bromo, CF3, CN, NO2, NHRf, en donde Rf representa hidrogeno, C1-8-alquilo (ramificado o no ramificado) o fenilo eventualmente sustituido, SR9, en donde R9 representa hidrogeno, C1-8-alquilo (ramificado o no ramificado), fenilo, piridina, bencilo o fluorenilo, ORh, en donde Rh representa C1-8-alquilo (ramificado o no ramificado), fenilo eventualmente sustituido, o CO(OR') (R' = C1-8-alquilo (ramificado o no ramificado) CO (OR') o CH2CO (OR'), teniendo R' el significado arriba indicado, o en el caso del grupo CH CO (OR') También representa hidrogeno, o un radical fenilo eventualmente sustituido y sus sales farmacéuticamente aceptables, exceptuando los compuestos, en donde simultáneamente R1 representa C (CH3)3, R2 representa hidrogeno, R3 representa fenilo sustituido, X representa S e Y representa N o CR6 con R6 = hidrogeno o CH2-CO2-etilo o simultáneamente R1 representa C (CH3)3, R2 representa hidrogeno, R3 representa fenilo no sustituido, Y representa NH y X representa N o CR5 con R5 = CO2 etilo.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE19948434A DE19948434A1 (de) | 1999-10-08 | 1999-10-08 | Substanzbibliothek enthaltend bicyclische Imidazo-5-amine und/oder bicyclische Imidazo-3-amine |
| DE1999148436 DE19948436B4 (de) | 1999-10-08 | 1999-10-08 | Bicyclische Imidazo-5-aminderivate |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AR030030A1 true AR030030A1 (es) | 2003-08-13 |
Family
ID=26055216
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP000105252A AR030030A1 (es) | 1999-10-08 | 2000-10-05 | Imidazo-5-il-aminas biciclicas, medicamentos que las contienen, su uso para la preparacion de medicamentos y procedimiento para su preparacion |
Country Status (28)
| Country | Link |
|---|---|
| US (2) | US6657064B2 (es) |
| EP (1) | EP1218383B1 (es) |
| JP (1) | JP2003511456A (es) |
| KR (1) | KR20020068515A (es) |
| CN (1) | CN1211385C (es) |
| AR (1) | AR030030A1 (es) |
| AT (1) | ATE413403T1 (es) |
| AU (1) | AU781227B2 (es) |
| BR (1) | BR0014817A (es) |
| CA (1) | CA2388476C (es) |
| CO (1) | CO5200851A1 (es) |
| CY (1) | CY1110416T1 (es) |
| CZ (1) | CZ20021242A3 (es) |
| DE (1) | DE50015443D1 (es) |
| DK (1) | DK1218383T3 (es) |
| ES (1) | ES2316388T3 (es) |
| HU (1) | HUP0203140A3 (es) |
| IL (2) | IL149010A0 (es) |
| MX (1) | MXPA02002837A (es) |
| NO (1) | NO20021566L (es) |
| PE (1) | PE20010638A1 (es) |
| PL (1) | PL355019A1 (es) |
| PT (1) | PT1218383E (es) |
| RU (1) | RU2002110112A (es) |
| SI (1) | SI1218383T1 (es) |
| SK (1) | SK4642002A3 (es) |
| UY (1) | UY26370A1 (es) |
| WO (1) | WO2001027118A2 (es) |
Families Citing this family (24)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| BR0014817A (pt) * | 1999-10-08 | 2002-06-18 | Gruenenthal Gmbh | Imidazo-5-il-aminas bicìclicas, medicamentos que as contém, seu emprego para a preparação de medicamentos e procedimento para sua preparação |
| AU2001251444A1 (en) | 2000-04-10 | 2001-10-23 | Merck And Co., Inc. | Inhibitors of prenyl-protein transferase |
| DE10043845A1 (de) * | 2000-09-06 | 2002-03-14 | Gruenenthal Gmbh | Verfahren zur Messung der Aktivität der NO-Synthase |
| KR100647583B1 (ko) * | 2003-10-07 | 2006-11-17 | 삼성에스디아이 주식회사 | 이미다졸 고리 함유 화합물 및 이를 이용한 유기 전계발광 소자 |
| WO2006065788A2 (en) * | 2004-12-13 | 2006-06-22 | Glaxo Group Limited | Novel muscarinic acetylcholine receptor antagonists |
| US7923041B2 (en) * | 2005-02-03 | 2011-04-12 | Signum Biosciences, Inc. | Compositions and methods for enhancing cognitive function |
| DE102006011574A1 (de) * | 2006-03-10 | 2007-10-31 | Grünenthal GmbH | Substituierte Imidazo[2,1-b]thiazol-Verbindungen und ihre Verwendung zur Herstellung von Arzneimitteln |
| DK2029602T3 (da) * | 2006-05-31 | 2010-08-09 | Galapagos Nv | Triazolopyrazinforbindelser, der kan anvendes til behandling af degenerative og inflammatoriske sygdomme |
| US8227603B2 (en) * | 2006-08-01 | 2012-07-24 | Cytokinetics, Inc. | Modulating skeletal muscle |
| WO2008016648A2 (en) * | 2006-08-01 | 2008-02-07 | Cytokinetics, Incorporated | Certain chemical entities, compositions and methods |
| US8299248B2 (en) | 2006-08-02 | 2012-10-30 | Cytokinetics, Incorporated | Certain 1H-imidazo[4,5-b]pyrazin-2(3H)-ones and 1H-imidazo[4,5-b]pyrazin-2-ols and methods for their use |
| AU2007281468B2 (en) * | 2006-08-02 | 2012-12-06 | Cytokinetics, Incorporated | Certain chemical entities, compositions and methods |
| US7851484B2 (en) * | 2007-03-30 | 2010-12-14 | Cytokinetics, Inc. | Certain chemical entities, compositions, and methods |
| WO2009061856A1 (en) * | 2007-11-09 | 2009-05-14 | The Salk Instituite For Biological Studies | Non-nucleoside reverse transcriptase inhibitors |
| WO2009128383A1 (ja) | 2008-04-15 | 2009-10-22 | エーザイ・アール・アンド・ディー・マネジメント株式会社 | ３－フェニルピラゾロ［５，１－ｂ］チアゾール化合物 |
| ES2632220T3 (es) * | 2009-06-15 | 2017-09-11 | Rigel Pharmaceuticals, Inc. | Inhibidores de moléculas pequeñas de tirosina cinasa del bazo (SYK) |
| AR078521A1 (es) | 2009-10-08 | 2011-11-16 | Eisai R&D Man Co Ltd | Compuesto pirazolotiazol |
| CN109316480A (zh) | 2011-07-13 | 2019-02-12 | 赛特凯恩蒂克公司 | 组合als疗法 |
| CN104640869B (zh) | 2012-04-26 | 2017-12-12 | 百时美施贵宝公司 | 作为用于治疗血小板聚集的蛋白酶激活受体4(par4)抑制剂的咪唑并噻二唑和咪唑并哒嗪衍生物 |
| CN104583218B (zh) | 2012-04-26 | 2018-04-24 | 百时美施贵宝公司 | 作为蛋白酶活化受体4(par4)抑制剂用于治疗血小板聚集的咪唑并噻二唑和咪唑并吡嗪的衍生物 |
| JP6181744B2 (ja) | 2012-04-26 | 2017-08-16 | ブリストル−マイヤーズ スクイブ カンパニーＢｒｉｓｔｏｌ−Ｍｙｅｒｓ Ｓｑｕｉｂｂ Ｃｏｍｐａｎｙ | 血小板凝集を治療するためのプロテアーゼ活性化受容体４（ｐａｒ４）阻害剤としてのイミダゾチアジアゾール誘導体 |
| US9598419B1 (en) | 2014-06-24 | 2017-03-21 | Universite De Montreal | Imidazotriazine and imidazodiazine compounds |
| US9617279B1 (en) | 2014-06-24 | 2017-04-11 | Bristol-Myers Squibb Company | Imidazooxadiazole compounds |
| KR102599388B1 (ko) * | 2017-09-01 | 2023-11-09 | 현대자동차주식회사 | 피드백 제어방법 및 시스템 |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TW274551B (es) * | 1991-04-16 | 1996-04-21 | Takeda Pharm Industry Co Ltd | |
| BR0014817A (pt) * | 1999-10-08 | 2002-06-18 | Gruenenthal Gmbh | Imidazo-5-il-aminas bicìclicas, medicamentos que as contém, seu emprego para a preparação de medicamentos e procedimento para sua preparação |
-
2000
- 2000-09-18 BR BR0014817-2A patent/BR0014817A/pt not_active IP Right Cessation
- 2000-09-18 KR KR1020027004442A patent/KR20020068515A/ko not_active Withdrawn
- 2000-09-18 MX MXPA02002837A patent/MXPA02002837A/es active IP Right Grant
- 2000-09-18 SI SI200031017T patent/SI1218383T1/sl unknown
- 2000-09-18 DE DE50015443T patent/DE50015443D1/de not_active Expired - Lifetime
- 2000-09-18 AT AT00967693T patent/ATE413403T1/de active
- 2000-09-18 CN CNB008163650A patent/CN1211385C/zh not_active Expired - Fee Related
- 2000-09-18 CA CA002388476A patent/CA2388476C/en not_active Expired - Fee Related
- 2000-09-18 JP JP2001530336A patent/JP2003511456A/ja not_active Withdrawn
- 2000-09-18 DK DK00967693T patent/DK1218383T3/da active
- 2000-09-18 HU HU0203140A patent/HUP0203140A3/hu unknown
- 2000-09-18 ES ES00967693T patent/ES2316388T3/es not_active Expired - Lifetime
- 2000-09-18 CZ CZ20021242A patent/CZ20021242A3/cs unknown
- 2000-09-18 RU RU2002110112/04A patent/RU2002110112A/ru not_active Application Discontinuation
- 2000-09-18 AU AU77772/00A patent/AU781227B2/en not_active Ceased
- 2000-09-18 WO PCT/EP2000/009097 patent/WO2001027118A2/de not_active Ceased
- 2000-09-18 PT PT00967693T patent/PT1218383E/pt unknown
- 2000-09-18 SK SK464-2002A patent/SK4642002A3/sk not_active Application Discontinuation
- 2000-09-18 EP EP00967693A patent/EP1218383B1/de not_active Expired - Lifetime
- 2000-09-18 PL PL00355019A patent/PL355019A1/xx unknown
- 2000-09-18 IL IL14901000A patent/IL149010A0/xx active IP Right Grant
- 2000-10-02 CO CO00074644A patent/CO5200851A1/es not_active Application Discontinuation
- 2000-10-05 AR ARP000105252A patent/AR030030A1/es not_active Application Discontinuation
- 2000-10-05 UY UY26370A patent/UY26370A1/es not_active Application Discontinuation
- 2000-10-06 PE PE2000001066A patent/PE20010638A1/es not_active Application Discontinuation
-
2002
- 2002-04-03 NO NO20021566A patent/NO20021566L/no not_active Application Discontinuation
- 2002-04-04 IL IL149010A patent/IL149010A/en not_active IP Right Cessation
- 2002-04-08 US US10/117,335 patent/US6657064B2/en not_active Expired - Fee Related
-
2003
- 2003-08-05 US US10/633,579 patent/US6936631B2/en not_active Expired - Fee Related
-
2009
- 2009-01-28 CY CY20091100104T patent/CY1110416T1/el unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AR030030A1 (es) | Imidazo-5-il-aminas biciclicas, medicamentos que las contienen, su uso para la preparacion de medicamentos y procedimiento para su preparacion | |
| CO5210861A1 (es) | Biblioteca de sustancias que contienen imidazo-5-il-aminas biciclicas y/o imidazo 3-il-aminas biciclicas, procedimiento para la prepraracion de esta biblioteca de sustancias y uso de sustancias de esta biblioteca para la preparacion de medicamentos p | |
| CO4650033A1 (es) | Derivados de lactama con actividad selectiva agonista y antagonista de receptores de serotonina 1 (5ht) y composiciones farmaceuticas que los contienen . | |
| CO5011090A1 (es) | Derivados de acil-piperazinil-pirimidinas, procedimiento para su preparacion y composiciones farmaceuticas de los mismos | |
| CO6290657A2 (es) | Derivados polisustituidos de 2-aril-6-fenil-imidazo[1,2-alfa]piridinas su preparacion y su aplicacion en terapeutica | |
| AR015763A1 (es) | Indolinonas sustituidas y sus sales fisiologicamente compatibles, un procedimiento para su preparacion, su empleo para la preparacion de un medicamento, losmedicamentos que las contienen y un procedimiento para la preparacion de estos medicamentos | |
| CO5540280A2 (es) | Derivados aromaticos de acido dicarboxilico | |
| ES2165768B1 (es) | Nuevos derivados de quinuclidina y composiciones farmaceuticas que los contienen. | |
| NO20042584L (no) | Dibenzylaminforbindelser og farmasoytisk anvendelse derav | |
| AR064517A1 (es) | Pirimidinionas biciclicas y sus usos | |
| AR041260A1 (es) | Piperazinas sustituidas por heterociclos para el tratamiento de la esquizofrenia | |
| TWI263636B (en) | Fluorescent maleimides and use thereof | |
| AR025386A1 (es) | Moduladores de los receptores activados del proliferador de peroxisomas | |
| ES2315853T3 (es) | Tetrahidroquinolinonas y su uso como antagonistas de receptores de glutamato metabotropico. | |
| CO5601002A2 (es) | Inhibidores de la acc | |
| ES464136A1 (es) | Procedimiento para la preparacion de derivados de quinazolo-na. | |
| AR048567A1 (es) | Derivados de benzoxazinona, su preparacion y composiciones farmaceuticas. | |
| CO5630029A2 (es) | Derivados de indol e indolina sustituidos | |
| ES409603A1 (es) | Procedimiento para la obtencion de colorantes reactivos concelulosa. | |
| AR118082A1 (es) | Inhibidores de enzimas | |
| CO5210870A1 (es) | Imidazo-3-il-aminas biciclicas procedimiento para su preparacion y medicamentos que las contienen | |
| CO4960656A1 (es) | Derivados del 2-(4-aril o heteroaril-piperazin-1-ilmetil)1h- indol | |
| DK351788A (da) | Tetrahydroisoquinolin-2-ylderivater af carboxylsyrer som thromboxan-a2-antagonister | |
| Verma et al. | A study of conformation about the aryl CN bonds in N-aryl imides by dynamic NMR spectroscopy | |
| AR034206A1 (es) | Un procedimiento para la preparacion de mesilatos de derivados de piperazina y dichos mesilatos |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FA | Abandonment or withdrawal |